Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 717 (USA) (Dr. Reyes)
· consented 2014-01-11
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild FATIGUE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-01 (study day 22.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild FATIGUE — outcome: RECOVERED/RESOLVED; onset 2014-02-01 (study day 22.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild NASAL CONGESTION — outcome: RECOVERED/RESOLVED; onset 2014-02-01 (study day 22.0); relationship: REMOTE
moderate
assessed
2026-08-18
Moderate NAUSEA — outcome: RECOVERED/RESOLVED; onset 2014-02-28 (study day 49.0); relationship: REMOTE
moderate
assessed
2026-08-18
Moderate VOMITING — outcome: RECOVERED/RESOLVED; onset 2014-02-28 (study day 49.0); relationship: REMOTE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.